Estofert 17 Beta Tablet

Estofert 17 Beta Tablet contains estradiol, an active ingredient belonging to vaginal Hormone Replacement Therapy (HRT) medicines. It is a synthetic estrogen with properties identical to the hormone naturally produced by women's ovaries. The tablet is indicated for treatment of menopausal symptoms including vaginal atrophy (dryness or irritation of the vagina) in elderly women who have completed menopause.

Do not use Estofert 17 Beta Tablet if you are allergic to estradiol or any of its constituents. It is contraindicated in patients with breast cancer or any oestrogen receptor-sensitive cancer. Do not use this tablet if you have a clotting disorder, blood clots in the veins of the lungs or legs, or unexplained vaginal bleeding. It is not recommended for patients with a history of heart attack, stroke, angina, or abnormal liver function tests. Estofert 17 Beta Tablet is not given to patients with porphyria, a rare inherited blood disorder.

Estrogen intake elevates the risk of gallbladder disease. Discontinue use if you experience cholestatic jaundice, severe hypertriglyceridemia, severe hypercalcemia, or vision loss. Close monitoring is advised in women receiving thyroid replacement treatment. Inform your doctor if you have vaginal bleeding, heart, kidney, lung or liver problems, diabetes, asthma, high blood pressure, or hearing disorder. Discuss with your doctor if you are planning pregnancy, may be pregnant, or are breastfeeding. Share your complete medical history with your healthcare provider. Inform your healthcare provider about all medicines you are taking, including herbal products, vitamin supplements, and over-the-counter medicines.

Relieve menopausal symptoms of 'vaginal atrophy' (in the vagina such as dryness or irritation) Treatment for hypogonadism, castration, or primary ovarian failure-related hypoestrogenism Preventing osteoporosis after menopause

Estofert 17 Beta Tablet primarily acts by binding to estrogen receptors (ERs) present on the surface of target cells upon binding to its receptor, Estofert 17 Beta Tablet induces a conformational change in the receptor, leading to its activation. Estofert 17 Beta Tablet replaces estrogen (female sex hormone) and prevents the symptoms of menopause, like vaginal irritation or dryness.

Take Estofert 17 Beta Tablet exactly as prescribed by your healthcare provider. Do not adjust the dosage or frequency without consulting your doctor. Take your Estofert 17 Beta Tablet at the same time each day to maintain a consistent level of hormones in your body. Swallow the Estofert 17 Beta Tablet whole with a glass of water. Do not crush, chew, or break the tablet, as this may affect its effectiveness or increase the risk of side effects.

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Common Headache Stomach pain Vaginal bleeding Discharge or discomfort. Serious: Ovarian cancer Blood clots Heart attack Breast lumps Stroke

It is recommended to examine your breast (mammogram) to avoid the risk of breast cancer caused by the drug and inform your doctor if you have any changes in skin colour. Don't apply it on your breast, eye, or other part of the body apart from the application site. Inform your doctor if you have uterus cancer or a history of blood clots. Regularly monitoring liver function tests, thyroid tests, bone mineral density, and blood pressure is advised as treatment with Estofert 17 Beta Tablet can alter these values.